Le Lézard
Classified in: Science and technology
Subject: Personnel

PlanetOne Elevates Chris Werpy to President and Jake Schuman to Senior Vice President


PlanetOne Founder and CEO Ted Schuman today appointed Chris Werpy to President and Jake Schuman to Senior Vice President. The news comes after an incredible year of growth, enablement, and success in PlanetOne's 30-year history.

"Since 1992, PlanetOne has always differentiated on experience and execution, and operated with a growth mindset that if everything seems under control, we're not going fast enough,'" says Schuman. "I'm proud to say over the last 18 months with Werpy as COO and Jake focused on the origin and continued advancement of SENTIENT, PlanetOne is faster, stronger and operating with more precision and focus. The positive business impact generated and inspired by these two business leaders runs wide and deep."

In 2021, the PlanetOne team changed its engagement model, embracing new processes and unveiling SENTIENT, a disruptive, intelligent enterprise-grade sales engagement and enablement platform powered by AI. The moves resulted in a record year that positions PlanetOne for explosive expansion in 2022 and beyond. Among the key highlights:

- Eclipsing all previous year in sales and income records, as well as new partner recruitment and share of wallet with existing partners and providers.

- Increasing the average revenue order per partner using SENTIENT by 70 percent.

- Expanding the PlanetOne staff by 25% including the hiring of powerhouse Karie (Kat) Atwood, vice president of supplier management, PlanetOne.

- Building out PlanetOne's provider portfolio by 60% across key technology categories including advanced security, collaboration and voice, connectivity, cloud and mobility.

- Architecting a new PlanetOne Partner Program under the leadership of Atwood.

Werpy joined PlanetOne in July 2020 as COO. His task: Take the team and the business to epic levels of energy and execution. Fast forward 18 months and Werpy's fingerprints and "let's go" mindset are easy to spot throughout PlanetOne's operations.

Jake joined PlanetOne in 2014 as a Partner Development Manager. Over the years, he took on a variety of roles, learning the business inside and out. In recognition of his growing leadership in operations and innovation, Jake was promoted to General Manager of the Costa Mesa, Calif., office and Vice President of PlanetOne in January 2020. A member of the executive leadership team, Jake conceptualized and launched PlanetOne's ground-breaking BI-infused platform SENTIENT, which launched in Sept. 2021.

"Huge congrats to Werpy and Jake on their promotions," concludes Schuman. "And cheers to our entire team and all the partners and providers who do business with PlanetOne ? let's go!"

For more information about PlanetOne, visit www.planetone.net, Facebook, Twitter, LinkedIn and YouTube.


These press releases may also interest you

at 07:45
The "Laboratory Filtration Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Laboratory Filtration Equipment Market to Reach $3 Billion by 2030 The global market for Laboratory...

at 07:42
Reference is made to Akastor ASA's (OSE: AKAST) announcement dated 18 April 2024 on the arbitration award issued in respect of the DRU contracts. Payment of the principal sums awarded, in total USD 108 million (exclusive interest), has now been...

at 07:40
The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...

at 07:35
IonQ , a leader in the quantum computing industry, announced today the appointment of Peter Chapman as its next Chairman of the Board and Harry You as the Lead Independent Director of the Board, effective at the close of IonQ's upcoming Annual...

at 07:35
Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company's proprietary Targeted RNAi Molecule...

at 07:35
Reports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable Impact of $0.08 Per Share Related to Acquired IPR&D and...



News published on and distributed by: